Previous 10 | Next 10 |
2024-05-22 17:00:09 ET Evan Seigerman from BMO Capital issued a price target of $36.00 for PFE on 2024-05-22 15:48:00. The adjusted price target was set to $36.00. At the time of the announcement, PFE was trading at $29.6. The overall price target consensus is at $57.55 ...
2024-05-22 16:29:53 ET Summary Today, we take a more in-depth look at drug giant Pfizer Inc., which has experienced falling revenues as Covid-19 has become endemic. The acquisition of Seagen did add blockbuster oncology therapies to Pfizer's portfolio, boosting sagging oncology sa...
2024-05-22 14:00:26 ET More on BioNTech, Moderna, etc. Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Pfizer Stock: Rebound Has Started (Technical Analysis) Pfizer launchi...
2024-05-22 12:59:29 ET More on Pfizer Pfizer tax practices targeted by Senate Finance Committee Chair Wyden Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs ...
2024-05-21 17:22:48 ET More on Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Pfizer Stock: Rebound Has Started (Technical Analysis) Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield Pfizer agrees t...
2024-05-21 10:00:00 ET Summary Pfizer shares have lagged behind the pharma rally due to inflated expectations, one-time losses, write-offs, and the Seagen acquisition. The company is expecting an LOE wave with 6 names facing patent expirations, leading to a $17 billion sales decli...
2024-05-21 07:30:00 ET Summary Retirement investing can be challenging due to diverse needs and unique financial situations. Inflation reduces purchasing power and higher withdrawal rates impact net worth, making high-quality income stocks important. I highlight two ETFs and t...
2024-05-21 06:27:00 ET The past couple of years haven't been easy ones to be a Pfizer (NYSE: PFE) shareholder. The windfall profits its COVID-19 products produced in the early days of the pandemic evaporated much faster than expected. Disappointed investors have pushed Pfizer's ...
2024-05-20 09:58:45 ET More on PTC Therapeutics PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript PTC Therapeuti...
2024-05-20 04:37:00 ET Investors looking to pad their passive income streams with high-yield dividend stocks have three excellent choices. If you have an extra $100 to invest, you could set yourself up with dividends from Realty Income (NYSE: O) , Altria Group (NYSE: MO) , o...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...